4 unknown, 1 not yet recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Not yet recruiting 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Hua Li: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC Icariin Soft Capsules+TACE - Hepatocarcinoma | Phase 2 | Not yet recruiting | Hua Li | 25 | 2025-03-30 | 2025-03-28 |
| Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies lenvatinib + anti-PD-1 antibodies, ablation - Hepatocellular Carcinoma | Phase 1 | Unknown | Hua Li | 70 | 2024-01-01 | 2024-07-24 |
| Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model Personalized Cancer Treatment | Unknown | Hua Li | 40 | 2023-09-01 | 2024-01-30 | |
| Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma Camrelizumab, Gemcitabine Injection, Cisplatin injection - Unresectable Intrahepatic Cholangiocarcinoma | Phase 2 | Unknown | Hua Li | 22 | 2023-06-30 | 2023-11-29 |
| Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients Medroxyprogesterone Acetate 500 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine System - Fertility Sparing | Phase 2 / Phase 3 | Unknown | Hua Li | 148 | 2022-11-01 | 2022-10-04 |
Cisplatin (1) · Gemcitabine (1) · Medroxyprogesterone Acetate (1) · Tablets (1) · camrelizumab (1) · lenvatinib (1)
China (5)